AIP Publishing LLC
AIP Publishing LLC
  • pubs.aip.org
  • AIP
  • AIP China
  • University Science Books
  • Resources
    • Researchers
    • Librarians
    • Publishing Partners
    • Topical Portfolios
    • Commercial Partners
  • Publications

    Find the Right Journal

    Explore the AIP Publishing collection by title, topic, impact, citations, and more.
    Browse Journals

    Latest Content

    Read about the newest discoveries and developments in the physical sciences.
    See What's New

    Publications

    • Journals
    • Books
    • Physics Today
    • AIP Conference Proceedings
    • Scilight
    • Find the Right Journal
    • Latest Content
  • About
    • About Us
    • News and Announcements
    • Careers
    • Events
    • Leadership
    • Contact
  • pubs.aip.org
  • AIP
  • AIP China
  • University Science Books

Artificial Pancreas Reduces Disease Management Burden for People with Diabetes

  • May 23, 2023
  • APL Bioengineering
  • News
Share:

From the Journal: APL Bioengineering

WASHINGTON, May 23, 2023 – Type 1 diabetes affects 46.3 million people worldwide, and the number of people affected increases by about 3% each year. It requires careful calculations of insulin needs and bothersome daily injections to avoid peripheral diseases caused by extremes of high or low blood sugar.

Automated insulin delivery systems, also called artificial pancreases, make diabetes management much less onerous for patients. These systems — with implanted insulin sensors, pumps that deliver insulin inside the body, associated insulin pump controllers, and increasingly sophisticated control algorithms — are rapidly advancing.

Advancements in automated insulin delivery technology, particularly elimination of the need for interactions with insulin delivery devices to manually enter estimates of carbohydrates in meals consumed, are significantly reducing the burden of disease management for patients with diabetes. Credit: Claudio Cobelli
Advancements in automated insulin delivery technology, particularly elimination of the need for interactions with insulin delivery devices to manually enter estimates of carbohydrates in meals consumed, are significantly reducing the burden of disease management for patients with diabetes. Credit: Claudio Cobelli

In APL Bioengineering, by AIP Publishing, researchers from the University of Padova, University of Pavia, and Yale University designed a novel algorithm for controlling implanted insulin pumps that accounts for the unique characteristics of individual patients. Their model, tested using an FDA-approved diabetes computer simulation, proves intraperitoneal (within the abdominal cavity) insulin delivery is fast and closely mimics natural physiological insulin delivery.

“Not only is intraperitoneal infusion of insulin much more physiological because you are reproducing the natural physiology, but it simplifies the control problem because you don’t have delays,” author Claudio Cobelli said. “So, this means you can have a very simple, robust controller to handle the everyday situations.”

The current method of automated insulin delivery, which is based on technology called continuous subcutaneous glucose sensors, requires patients to manually enter the number of carbohydrates they consume, announcing their meals to the system before they eat. It is also slow to sense and deliver insulin. These delays, along with the likelihood of errors in manual meal calculations, make the system prone to inaccuracies and increase the prevalence of hyperinsulinemia, a state of high insulin in patients that causes diseases of the large blood vessels.

Using an FDA-accepted simulator designed for continuous subcutaneous insulin delivery, the researchers made modifications to simulate intraperitoneal insulin delivery. They developed a model that can account for individual patient differences and validated a pump control algorithm that does not require meal announcement.

“This is a big plus. It helps with tuning the devices and allows personalization,” Cobelli said. “Different people have different needs, so you need to personalize the algorithms.”

Tying together previous work and current experiments, the researchers successfully showed the similarities between intraperitoneal insulin delivery and the physiology of natural insulin secretion and validated a pump control algorithm that is robust to personalization factors and time variance for breakfast, lunch, and dinner meals.

Their work is part of a multiyear, collaborative European project called “FORGET DIABETES” that aims to rapidly advance automated insulin delivery technologies to the point of clinical trials.

###

Article Title

In silico design and validation of a time-varying PID controller for an artificial pancreas with intraperitoneal insulin delivery and glucose sensing

Authors

Alberto Dalla Libera, Chiara Toffanin, Martina Drecogna, Alfonso Galderisi, Gianluigi Pillonetto, and Claudio Cobelli

Author Affiliations

University of Padova, University of Pavia, Yale University


APL Bioengineering

APL Bioengineering is devoted to research at the intersection of biology, physics, and engineering. The journal publishes high-impact manuscripts specific to the understanding and advancement of physics and engineering of biological systems. APL Bioengineering is the new home for the bioengineering and biomedical research communities.

https://aip.scitation.org/journal/apb

Share:
  • Electronic Noses Sniff Out Volatile Organic Compounds
  • How Insects Track Odors by Navigating Microscale Winds

Keep Up With AIP Publishing

Sign up for the AIP newsletter to receive the latest news and information from AIP Publishing.
Sign Up

AIP PUBLISHING

1305 Walt Whitman Road,
Suite 110
Melville, NY 11747
(516) 576-2200

Resources

  • Researchers
  • Librarians
  • Publishing Partners
  • Commercial Partners

About

  • About Us
  • Careers 
  • Leadership

Support

  • Contact Us
  • Terms Of Use
  • Privacy Policy

© 2025 AIP Publishing LLC